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ABSTRACT 
Objective: To develop an accurate, precise and linear Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method for 
simultaneous quantitative estimation of Mebeverine hydrochloride and Chlordiazepoxide in MEVA C capsules and validate as per ICH guidelines.  
Methods: The optimized method uses a reverse phase column, Enable Make C18G (250 X 4.6 mm; 5μ), a mobile phase of triethylammonium 
phosphate buffer (pH 2.5): acetonitrile in the proportion of 60:40 v/v, flow rate of 1.0 ml/min and a detection wavelength of 240 nm using a UV 
detector.  
Results: The developed method resulted in Mebeverine eluting at 5.8 min and Chlordiazepoxide at 3.9 min. Mebeverine exhibited linearity in the 
range 250-750μg/ml, while Chlordiazepoxide exhibited linearity in the range 9.25-27.75μg/ml. The precision is exemplified by relative standard 
deviations of 1.45% for Mebeverine and 1.58% for Chlordiazepoxide. Percentage Mean recoveries were found to be in the range of 98-102, during 
accuracy studies. The limit of detection (LOD) for Mebeverine hydrochloride and Chlordiazepoxide were found to be 91.67µg/ml and 2.23µg/ml 
respectively, while limit of quantitation (LOQ) for Mebeverine hydrochloride and Chlordiazepoxide were found to be 277.81µg/ml and 6.77µg/ml 
respectively. 
Conclusion: A simple, accurate, precise, linear and rapid RP-HPLC method was developed for simultaneous quantitative estimation of Mebeverine 
hydrochloride and Chlordiazepoxide in MEVA C capsules and validated as per ICH guidelines. Hence it can be used for the routine analysis of 
Mebeverine and Chlordiazepoxide in capusles in various pharmaceutical industries.  
Keywords: RP-HPLC, Mebeverine, Chlordiazepoxide, Method development, Validation. 
 
Mebeverine hydrochloride (fig. 1) is a white crystalline powder 













HCl, molecular weight 466 
and melting point 105-107ºC. It is freely soluble in water and 
ethanol (96%), while practically insoluble in diethyl ether[1]. IUPAC 
name of Mebeverine hydrochloride is 3,4-Dimethoxybenzoic acid 4-
[ethyl[2-(4-methoxy phenyl)-1-methylethyl]amino]-butyl ester. It is 
a direct antispasmodic acting mainly on the smooth muscles of the 
gastrointestinal tract and particularly effective against the colonic 
spasm[2]. Mebeverine hydrochloride is widely used as a relaxant 
agent for the treatment of gastrointestinal spasmodic disorders such 
as irritable bowel syndrome [3]. 
 
Fig. 1: Structure of Mebeverine hydrochloride 
 
Chlordiazepoxide (fig. 2) is a first among the class of 
benzodiazepines to be used clinically as anti-anxiety drug [4]. 
Chlordiazepoxide is a white crystalline powder possessing solubility 
in water, whose IUPAC name is (7-chloro-2(methyl amino)-5-
phenyl-3-H-1,4 benzodiazepine 4-oxide). Chlordiazepoxide mainly 
acts on limbic system and ascending reticular formation in the 
central nervous system. It binds to stereo specific benzodiazepine 
binding sites on GABA receptor complexes at several sites within the 
central nervous system including the limbic system and reticular 
formation. The binding will facilitates GABA mediated chloride 
channel opening and produce hyperpolarisation. This will increase 
the concentration of inhibitory neurotransmitter GABA and chloride 
ions in the CNS and decreases firing rate of neurons [5]. Mebeverine 
hydrochloride (135mg) and Chlordiazepoxide (5mg) is 
commercially available as capsules (trade name: MEVA C). 
 
Fig. 2: Structure of Chlordiazepoxide 
 
A detailed literature survey reveals that there exists literature 
concerning analytical method development and validation for 
individual drugs Mebeverine [1,3,6-7] and Chlordiazepoxide [8-13] 
in various matrices. Also analytical methods are reported for 
Mebeverine with other drug combinations [2,14-19] and similarly 
Chlordiazepoxide with other drug combinations[4,20-23]. While 
there is only one literature reported on RP-HPLC method 
development and validation for the simultaneous quantitative 
estimation of Mebeverine and Chlordiazepoxide in pharmaceutical 
dosage forms [24]. Hence we have explored in developing a new, 
accurate, precise and linear RP-HPLC method for the simultaneous 
quantitative estimation of Mebeverine and Chlordiazepoxide in 
MEVA C capsules and validate as per ICH guidelines. 
MATERIALS AND METHODS 
Chemicals and reagents 
Analytically pure sample of Mebeverine and Chlordiazepoxide with 
purities greater than 99% were obtained as gift samples from 
Chandra Labs, Hyderabad, India and tablet formulation [ MEVA C] 
was procured from Medplus pharmacy, Hyderabad, India with 
labelled amount 5mg and 135mg of Chlordiazepoxide and 
Mebeverine respectively. Acetonitrile (HPLC grade) was obtained 
from Sigma aldrich (Hyderabad, India), water (HPLC grade), 
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Triethylamine (AR grade), ortho phosphoric acid (AR Grade) were 
obtained from SD Fine chemicals (Hyderabad, India), 0.45μm Nylon 
membrane filters were obtained from Spincotech Private Limited, 
Hyderabad, India.  
Instrument 
HPLC analysis was performed on Shimadzu LC-20AD Prominence Liquid 
Chromatograph comprising a LC-20AD pump, Shimadzu SPD-20A 
Prominence UV-VISIBLE detector and a reverse phase C18 column, 
Enable C18G (250 X 4.6 mm; 5μ). A manually operating Rheodyne 
injector with 20 μL sample loop was equipped with the HPLC system. 
The HPLC system was controlled with “Lab solutions lite” software. A 
double beam UV-visible spectrophotometer (Shimadzu, model 1800) 
having two matched quartz cells with 1 cm light path and loaded with UV 
probe software (version 2.41) was used for recording of spectra and 
measuring absorbance. An electronic analytical weighing balance (0.1mg 
sensitivity, Shimadzu AY 220), digital pH meter (DELUX model 101), a 
sonicator (sonica, model 2200 MH) and UV-Visible Spectrophotometer 
(Shimadzu UV-1800 series, software-UV probe version 2.42) were used 
in this study.  
Methods 
Selection of Wavelength 
Suitable wavelength for the HPLC analysis was determined by recording 
UV spectrums in the range of 200-400 nm for individual drug solutions 
of Chlordiazepoxide and Mebeverine. Suitable wavelength selected for 
simultaneous estimation is 240 nm (fig. 3-4). 
 
 
Fig. 3: UV spectrum of standard Mebeverine hydrochloride 
 
 
Fig. 4: UV spectrum of standard Chlordiazepoxide 
 
Preparation of stock and working standard solution for 
Mebeverine hydrochloride 
10mg of Mebeverine hydrochloride was accurately weighed and 
taken in 10 ml clean and dry volumetric flask containing 8 ml of 
solvent and then the solution was made up to the mark using the 
solvent. This is considered as standard stock solution (1000µg/ml). 
5 ml of the stock solution was pipetted out and made up to 10 ml to 
get a concentration 500µg/ml, treated as working standard, 100% 
target concentration.  
Preparation of stock and working standard solution for 
Chlordiazepoxide 
10mg of Chlordiazepoxide was accurately weighed and taken in 100 
ml clean and dry volumetric flask containing 80 ml of solvent and 
then the solution was made up to the mark using the solvent. This is 
considered as standard stock solution (100µg/ml). 1.85 ml of the stock 
solution was pipetted out and made up to 10 ml to get a concentration 
18.5µg/ml, treated as working standard, 100% target concentration.  
Preparation of stock and working sample solution 
Ten capsules were opened having white powder with tablet. Grinded 
totally uniformly and the average weight was determined. The 
average weight was transferred to a 100 ml volumetric flask 
containing 100 ml diluent and then stirred for 10 minutes, followed 
by filtration through 0.45µ nylon membrane filter to get sample 
stock solution of 1.35mg/ml of Mebeverine hydrochloride and 
50µg/ml. 3.7 ml of the above stock solution was pipetted out and 
made up to 10 ml to get working sample solution equivalent to a 
concentration of working standard of 500µg/ml for Mebeverine 
hydrochloride and 18.5µg/ml for Chlordiazepoxide. 
RESULTS AND DISCUSSION 
Method development 
A Reverse phase HPLC method was developed keeping in mind the 
system suitability parameters i. e. resolution factor (Rs) between 
peaks, tailing factor (T), number of theoretical plates (N), runtime 
and the cost effectiveness. The optimized method developed 
resulted in the elution of Mebeverine at 5.8 min and 
chlordiazepoxide at 3.9 min. Fig. 5 and 6 represent chromatograms 
of blank solution and mixture of standard solution respectively. The 
total run time is 8 minutes. System suitability tests are an integral 
part of method development and are used to ensure adequate 
performance of the chromatographic system. Retention time (Rt), 
number of theoretical plates (N), peak resolution (Rs) and peak 
Tailing factor (T) was evaluated for six replicate injections of the 
standards at the working concentration. The results given in table 1 
were within acceptable limits.  
 
 
Fig. 5: Typical Chromatogram of Blank solution 
 
 
Fig. 6: Typical chromatogram of Mebeverine standard solution 
 
 
Fig. 7: Typical chromatogram of Chlordiazepoxide standard 
solution 
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Table 1: System suitability studies results. 
Parameters Acceptance Limits Mebeverine Chlordiazepoxide 
Retention time (min) - 5.8 3.9 
Resolution factor (Rs) Not less Than 2 4.028 
Number Of Theoretical plates (N)  Not less Than 2000 2754 2738 
Tailing factor (T)  Not More Than 2 1.5  1.1 
 
In order to test the applicability of the developed method to a 
commercial formulation, ‘MEVA C’ capsules were chromatographed 
at working concentration and it is shown in fig. 8. The sample peaks 
were identified by comparing the relative retention times with the 
standard drugs (fig. 6-7). System suitability parameters were within 
the acceptance limits, ideal for the chromatographed sample. 
Integration of separated peak area was done and each drug 
concentration was determined by using the peak area concentration 
relationship obtained in the standardization step. The protocol 
affords reproducible quantification of the two drugs with an error 
less than 10%, which is the standard level in any pharmaceutical 
quality control. 
 
Fig. 8: Typical chromatogram of the sample 
 
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. UV spectrophotometric method developed was 
validated according to International Conference on Harmonization 
(ICH) guidelines [25] for validation of analytical procedures. The 
method was validated for the parameters like linearity, accuracy, 
system precision, intra-day precision, inter-day precision/ 
intermediate precision/ ruggedness, robustness, limit of detection 
(LOD) and limit of quantitation (LOQ). 
Specificity 
Fig. 5-8 for blank, standard drug solutions and sample 
chromatogram reveal that the peaks obtained in the standard 
solutions and sample solution at working concentrations are only 
because of the drugs as blank has no peak at the retention time of 
Mebeverine and Chlordiazepoxide standards. Accordingly it can be 
concluded that, the method developed is said to be specific. 
Precision 
System precision 
Six replicate injections of the standard solutions at working 
concentration showed % RSD (Relative Standard Deviation) less 
than 2 concerning peak area for both the drugs, which indicates the 
acceptable reproducibility and thereby the precision of the system. 
System precision results are tabulated in table 2. 
Method precision 
Method precision was determined by performing the assay of the 
sample under the test of repeatability (intraday precision) at 
working concentrations.  
Repeatability (Intraday precision) 
Six consecutive injections of the sample from the same 
homogeneous mixture at working concentration showed % RSD less 
than 2 concerning % assay for both the drugs which indicate that the 
method developed is method precise by the test of repeatability and 
hence can be understood that the method gives consistently 
reproducible results (Table 3).  
 
Table 2: System precision results of Mebeverine and 
Chlordiazepoxide 
S. No. Mebeverine Chlordiazepoxide 
1 5669077.55 2314885 
2 5601566.47 2294885 
3 5674688.8 2281105 
4 5643246.25 2321465 
5 5674139.47 2289484 
6 5614483.05 2306987 
Average 5646200.26 2301468.5 
STD 32007.6535 15568.938 
%RSD 0.52249571 0.6764784 
 
Table 3: Intraday precision results of Mebeverine 
hydrochloride and Chlordiazepoxide 




1 99.7 98.1 
2 101.4 98.7 
3 98.4 102.2 
4 99.9 101.5 
5 101.6 100 
6 98.2 99.8 
Average 99.9 100.1 
S. D. 1.455427 1.5833392 
% RSD 1.457358 1.5822551 
 
Linearity 
Standard solutions of Mebeverine hydrochloride and 
Chlordiazepoxide at different concentrations level (50%, 75%, 
100%, 125%, and 150%) were prepared in triplicates. Calibration 
curves were constructed by plotting the concentration level versus 
corresponding peak areas for both the drugs. The results show an 
excellent correlation between peak areas and concentratiosn level 
within the concentration range of 250-750µg/ml for Mebeverin and 
9.25-27.75µg/ml for Chlodiazepoxide (Tables 4-5). The correlation 
coefficients were greater than 0.99 for both the drugs, which meet 
the method validation acceptance criteria and hence the method is 
said to be linear for both the drugs. 
Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of both the drugs in the 
formulation at three different levels (50-150%). At each level, three 
determinations were performed. Percent mean recovery is 
calculated as showed in table 6. The accepted limits of mean 
recovery are 98% -102% and all observed data were within the 
required range, which indicates good recovery values and hence the 
accuracy of the method developed. 
Ashok et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 2, 314-318 
317 
Table 4: Calibration data for Mebeverine 
% Level Concentration  Peak Area Peak Area Peak Area 
  (µg/ml) 1 2 3 
50 250 2882243 2654097 2609042 
75 375 4628074 4558396 4161541 
100 500 6091505 6213558 5351755 
125 625 7812321 8084952 6513541 
150 750 9462067 9510845 8116525 
Regression equation   y=13075x-362316 y=13792x-69165 y=10693.5x+3694 
Regression coefficient   0.999 0.997 0.996 
 
Table 5: Calibration data for Chlordiazepoxide 
% Level Concentration  Peak Area Peak Area Peak Area 
   (µg/ml) 1 2 3 
50 9.25 1188889 1019916 956907 
75 13.87 1791164 1664627 1550466 
100 18.5 2614885 2406932 2281105 
125 23.12 3260272 3150272 2873943 
150 27.75 4156826 4026826 3565136 
Regression equation  y=160111x-359331 y=162152x-545786 y=141405x-370208 
Regression coefficient   0.996 0.997 0.999 
 
Table 6: Results of Accuracy studies for Mebeverine hydrochloride and Chlordiazepoxide 
Concentration level (%) % Mean recovery mebeverine HCl % Mean recovery chlordiazepoxide 
50 99.53 99.52 
100 99.4 99.93 
150 99.08 99.07 
 
Sensitivity 
The sensitivity of measurement of Mebeverine hydrochloride 
and Chlordiazepoxide by use of the proposed method was 
estimated in terms of the limit of quantitation (LOQ) and limit of 
detection (LOD). LOQ and LOD were calculated by the use of the 
equations LOD = 3.3σ/S and LOQ = 10σ/S where σ is the 
standard deviation of intercepts of calibration plots and S is the 
average of the slopes of the corresponding calibration plot.  
The limit of detection (LOD) for Mebeverine hydrochloride and 
Chlordiazepoxide were found to be 91.67µg/ml and 2.23µg/ml 
respectively, while limit of quantitation (LOQ) for Mebeverine 
hydrochloride and Chlordiazepoxide were found to be 
277.81µg/ml and 6.77µg/ml respectively.  
CONCLUSION 
A reverse phase HPLC isocratic method developed has been 
validated as per ICH guidelines in terms of specificity, accuracy, 
precision, linearity, limit of detection and limit of quantitation, 
for for simultaneous quantitative estimation of Mebeverine 
hydrochloride and Chlordiazepoxide in MEVA C Capsules. The 
developed method resulted in Mebeverine eluting at 5.8 min and 
Chlordiazepoxide at 3.9 min. Mebeverine exhibited linearity in 
the range 250-750μg/ml, while Chlordiazepoxide exhibited 
linearity in the range 9.25-27.75μg/ml.  
The precision is exemplified by relative standard deviations of 
1.45% for Mebeverine and 1.58% for Chlordiazepoxide. 
Percentage Mean recoveries were found to be in the range of 
98-102, during accuracy studies. The limit of detection (LOD) for 
Mebeverine hydrochloride and Chlordiazepoxide were found to 
be 91.67µg/ml and 2.23µg/ml respectively, while limit of 
quantitation (LOQ) for Mebeverine hydrochloride and 
Chlordiazepoxide were found to be 277.81µg/ml and 6.77µg/ml 
respectively. 
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